🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to investigate the safety and tolerability of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-06-17
Trial ID
NCT00903786
Treatments Being Tested
Patients who have completed one of the core trials (E2007-E044-301 or E2007...
Status
Terminated
Location
Philipps-University Marburg
Start Date
2006-10
Trial ID
NCT00360412
Treatments Being Tested
The primary purpose of this study is to evaluate the efficacy of perampanel...
Status
Completed
Location
Eisai Site #9
Start Date
2022-10-19
Trial ID
NCT05533814
Treatments Being Tested
The purpose of this study is to investigate the safety, tolerability and ef...
Status
Completed
Location
Clinic of Neurology, Faculty Hospital Olomouc
Start Date
2004-05
Trial ID
NCT01172379
Treatments Being Tested
The purpose of the study is to determine the efficacy and safety of Perampa...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00592774
Treatments Being Tested
This study is designed to evaluate the pharmacokinetics, efficacy, and safe...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01527006
Treatments Being Tested
The purpose of this study is to explore the maximum tolerated dose of E2007...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00849212
Treatments Being Tested
This was a 22-week, prospective, randomized, double-blind, placebo-controll...
Status
Completed
Location
Investigational Site
Start Date
2005-01
Trial ID
NCT00154063
The primary objective of the present study will be to assess the effectiven...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-03
Trial ID
NCT04257604
Treatments Being Tested
This study will be conducted to demonstrate the bioequivalence between a si...
Status
Completed
Location
Eisai Trial Site
Start Date
2017-12-18
Trial ID
NCT03399734
Treatments Being Tested